Methods for reducing body fat using vitamin D compounds

Details Methods for reducing body fat using vitamin D compounds Methods for reducing body fat using vitamin D compounds

2006-05-30

2006-05-30

Qazi, Sabiha (Department: 1616)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

9,10-seco- cyclopentanohydrophenanthrene ring system doai

C552S653000

Reexamination Certificate

active

07053075

ABSTRACT:
A treatment for obesity and overweight comprises administering a vitamin D analog. The analog effectively inhibits an increase in body fat to animals at risk and decreases the basal fat content of animals. The treatment has a positive effect on the lean body component such that while there is an overall decrease in body weight, there is also a decrease in percent body fat. This decrease can be proportionally greater than the overall decrease in body weight. In addition, the treatment has a positive effect on bone turnover and osteogenesis making the vitamin D analog a beneficial treatment for the symptoms of menopause. Various exemplary embodiments of the treatment use the 2-alkylidene derivatives of vitamin D3, such as the 2-alkylidene-19-nor derivatives in both the R and S configurations at carbon-20.

REFERENCES:
patent: 5086191 (1992-02-01), DeLuca et al.
patent: 5536713 (1996-07-01), DeLuca et al.
patent: 5585369 (1996-12-01), DeLuca et al.
patent: 5843928 (1998-12-01), DeLuca et al.
patent: 6228393 (2001-05-01), DiCosmo et al.
patent: 6310105 (2001-10-01), Damodaran
patent: 6537981 (2003-03-01), DeLuca et al.
patent: 6566352 (2003-05-01), DeLuca et al.
patent: 6579861 (2003-06-01), DeLuca et al.
Wortsman et al, Decreased bioavailability of vitamin D in obesity, American Journal of Clinical Nutrition, 72:690-3, 2000.
Arunabh et al, Body fat content and 25-hydroxyvitamin D levels in healthy women, The Journal of Clinical Endocrinology & Metabolism, 88(1):157-161, Jan. 2003.
Kamycheva et al, Intakes of Calcium and Vitamin D Predict Body Mass Index in the Population of Northern Norway, Journal of Nutrition 132: 102-106, 2002, Copyright American Society for Nutritional Services.
Mark A. Moyad, Urologic Nursing, Feb. 2003, vol. 23, No. 1, 69-74.
Activation of Methylenetriphenylphosphorane by Reaction with t-Butyl-or sec—Butyllithium, Tetrahedron Letters, vol. 26, No. 5, pp 555-558, Corey et al.
Calciferol and its Relatives. Part 22.1A Direct Total Synthesis of Vitamin D2and Vitamin D32, Journal of the Chemical Society Perkin Transactions 1, pp 590-595, Lythgoe et al.
Novel Synthesis of 19-Nor-Vitamin D Compounds, Tetrahedron Letters, vol. 32, No. 52, pp 7663-7666, Perlman et al.
1a, 25-Dihydroxy-19-Nor-Vitamin D3, A Novel Vitamin D-Related Compound with Potential Therapeutic Activity, Tetrahedron Letters, vol. 31, No. 13, pp 1823-1824, Perlman et al.
The ovariectomized rat model of postmenopausal bone loss, Bone and Mineral, vol. 15, No. 3, pp 175-192, Kalu et al.
A potent analog of 1 , 25-dihydroxyvitamin D3selectivly induces bone formation, PNAS, vol. 99, No. 21, pp 13487-13491, Shevde et al.
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3Potently Stimulates Gene-specific DNA Binding of the Vitamin D Receptor in Osteoblasts, Journal of Biological Chemistry, vol. 278, No. 34, pp 31756-31765, Yamamoto et al.
24-and 26-homo-1,25-dihydroxyvitamin D3: Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro, Proc. Natl. Acad. Sci. USA, May 1987, vol. 84, pp 2610-2614, Ostrem et al.
Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol, Bone and Mineral, vol. 14, No. 3, (1991), pp 175-187, Kalu et al.
Stereocontrolled Total Synthesis of 1 ,25-Dihydroxycholecalciferol1and 1 ,25-Dihydroxyergocalciferol, J. Org. Chem, vol. 51, No. 16, (1986) pp 3098-3108, Baggiolini et al.
Studies on a Convergent Route to Side-Chain Analouges of Vitamin D: 25-Hydroxy-23-oxavitamin D21, J. Org. Chem., vol. 48, No. 9, (1983), pp 1414-1417, Toh et al.
Studies on the Synthesis of Side-Chain Hydroxylated Metabolites of Vitamin D3. Synthesis of 25-Ketovitamin Dand 25-Hydroxyvitamin D31, J. Org. Chem., vol. 51, No. 8, (1986), pp 1269-1272, Mascareñas et al.
Synthesis and Biological Activity of 2-Hydroxy and Alkoxy Analogs of 1a, 25-Dihydroxy-19-norvitamin D3, J. Org. Chem., vol. 37, No., 22,(1994), pp 3730-3738, Sicinski et al.
Synthetic Approaches to Vitamin D and its Relatives, Chemical Society Reviews, vol. 9, (1980), pp 449-475, Lythgoe et al.
The Wittig Reaction Using Methylsulfinyl Carbonion-Dimethyl Sulfoxide1, Dept. of Chemistry, Harvard University, Cambridge 38, Massachusetts, vol. 28, (1962), pp 1128-1129, Greenwald et al.

Affiliated with

Also associated with

Rating

Methods for reducing body fat using vitamin D compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for reducing body fat using vitamin D compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing body fat using vitamin D compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3547615